The Effectiveness of Anti-PD-1 Therapy in the Complex Treatment of Metastatic Melanoma of the Skin
Targeted and immunotherapy is important in the treatment of metastatic melanoma of the skin. The article presents a clinical case of a long-term follow-up of a patient with recurrent metastatic melanoma of the skin who received drug therapy using the anti-PD-1 drug nivolumab. The described clinical case demonstrates the possibilities of nivolumab monotherapy to increase the median survival and improve the quality of life of patients with metastatic melanoma of the skin, including discussion of the possibility of reinduction of immunotherapy against a pronounced comorbid background.